1321600-78-5: Imatinib N-Acetyl Impurity

Status: In-stock

Also known as Imatinib Di-Amide Impurity, it is an impurity present in Imatinib, Imatinib is a 2-phenylaminopyrimidine derivative, that act as a neoplastic agent. Imatinib is a protein-tyrosine kinase inhibitor that inhibits the BCR-ABL tyrosine kinase, the constitutively active tyrosine kinase, which is created by the Philadelphia chromosome abnormality in CML, activation is overexpressed in various tumors and is heavily implicated in cancer cells growth and survival, Imatinib inhibits the BCR-ABL protein by binding to the ATP pocket in the active site thus preventing downstream phosphorylation of target protein. which is used to treat several leukemias, myeloproliferative diseases, dermatofibrosarcoma protuberans, and gastrointestinal stromal tumors.

Additional information on CAS 1321600-78-5

Catalogue No. VE009742
CAS No. 1321600-78-5
Molecular Formula C31H33N7O2
Molecular Weight 535.64 g/mol
Parent drug Imatinib
IUPAC Name 4-[(4-Methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]-N-acetyl-amino}phenyl)benzamide
Synonyms Imatinib Di-Amide Impurity
References Iqbal, N., & Iqbal, N. (2014). Imatinib: A Breakthrough of Targeted Therapy in Cancer. Chemotherapy Research and Practice, 2014, 1–9. https://doi.org/10.1155/2014/357027
Status In-stock

Request a quote

We Respond Within a Few Hours - Whether You're a New or Existing Client

Payment Made Simple: All major Credit/Debit cards accepted

Streamlined 3-Step Process from Quotes to Orders:

Product name:

1321600-78-5: Imatinib N-Acetyl Impurity

"*" indicates required fields

Products quotation
This field is for validation purposes and should be left unchanged.